Wall Street Analysts Upgrade StubHub, Jazz Pharma, Four Others on Upside Potential
Six stocks receive buy upgrades from major firms, citing low expectations, strong earnings, and undervalued upside. Guggenheim upgraded StubHub to Buy with a $12.50 price target, up from $8.50, citing 30% potential upside after the company reset Street expectations for thi